Kimberly-Clark
KMB
Market cap $42.6B

128.29 USD

+0.33

0.26%

At close Jun 20, 4:00 PM EDT

After hours

128.29

+0.00

0.00%

1 day

0.26%

5 days

-4.09%

1 month

-9.42%

3 months

-7.76%

6 months

-2.31%

Year to date

-1.79%

1 year

-8.44%

5 years

-9.69%

10 years

17.73%

About: With more than half of its sales from personal care and another third from consumer tissue products, Kimberly-Clark is a leading manufacturer in the tissue and hygiene realm. Its brand mix includes Huggies, PullUps, Kotex, Depend, Kleenex, and Cottonelle. The firm also operates in the professional segment, partnering with businesses to provide safety and sanitary offerings for the workplace. Kimberly-Clark generates just over half its sales in North America and more than 10% in Europe, with the rest primarily concentrated in Asia and Latin America.

Employees: 38,000

Consumer Staples Household & Personal Products

0

Funds holding %

of 7,302 funds

0

Analysts bullish %

of 7 analysts

Fund manager confidence

Based on 2025 Q1 regulatory disclosures by fund managers ($100M+ AUM)

113% more call options, than puts

Call options by funds: $306M | Put options by funds: $144M

48% more first-time investments, than exits

New positions opened: 160 | Existing positions closed: 108

25% more funds holding in top 10

Funds holding in top 10: 4 [Q4 2024] → 5 (+1) [Q1 2025]

1% more funds holding

Funds holding: 1,751 [Q4 2024] → 1,767 (+16) [Q1 2025]

0% less capital invested

Capital invested by funds: $36.3B [Q4 2024] → $36.2B (-$84.3M) [Q1 2025]

1.66% less ownership

Funds ownership: 78.47% [Q4 2024] → 76.81% (-1.66%) [Q1 2025]

20% less repeat investments, than reductions

Existing positions increased: 587 | Existing positions reduced: 733

See Fund Rankings

Research analyst outlook

7 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target

$131

2%

upside

Avg. target

$146

14%

upside

High target

$162

26%

upside

7 analyst ratings

3 positive

43%

3 neutral

43%

1 negative

14%

Barclays Lauren Lieberman	5%upside $135	Equal-Weight Maintained	24 Apr 2025
RBC Capital Nik Modi	26%upside $162	Outperform Maintained	23 Apr 2025
Piper Sandler Korinne Wolfmeyer	22%upside $156	Overweight Maintained	23 Apr 2025
Evercore ISI Group Javier Escalante	21%upside $155	Outperform Maintained	23 Apr 2025
UBS Peter Grom	14%upside $146	Neutral Maintained	17 Apr 2025

See Analyst Rankings

Financial journalist opinion

Based on 15 articles about KMB published over the past 30 days

Zacks Investment Research

GO or KMB: Which Is the Better Value Stock Right Now?

Investors looking for stocks in the Consumer Products - Staples sector might want to consider either Grocery Outlet Holding Corp. (GO) or Kimberly-Clark (KMB). But which of these two stocks is more attractive to value investors?

GO or KMB: Which Is the Better Value Stock Right Now?

U by Kotex® Teams Up with #1 Pickleball Player Anna Leigh Waters to Help Smash Period Stigma in Sports

The Champion Athlete Proves Periods Don't Have to Sideline Performance CHICAGO , June 18, 2025 /PRNewswire/ -- The U by Kotex® Brand is taking a shot at period stigma through its new partnership with pickleball champion, Anna Leigh Waters , to challenge the outdated idea that periods hold athletes back.

U by Kotex® Teams Up with #1 Pickleball Player Anna Leigh Waters to Help Smash Period Stigma in Sports

Suzano: This Is Why The Market Like The JV With Kimberly-Clark

Suzano has proposed a 51% joint venture with Kimberly-Clark to jointly operate their tissue division outside the U.S. The deal covers Kimberly-Clark's tissue operations in Asia, Oceania, Europe, and Central America, spanning 22 mills in 14 countries. The share's upside is 38%, because the market can understand the JV as a first step for the company to have more diversified businesses.

Suzano: This Is Why The Market Like The JV With Kimberly-Clark

Secure Your Income: 3 Rock-Solid Dividend Stocks Yielding ~ 4%

I focus on four key criteria: long-term profit growth, high profitability, sustainable dividends, and attractive valuations for reliable passive income. Kimberly-Clark, General Mills, and PepsiCo all meet these standards, offering stable earnings, strong margins, and decades of uninterrupted, growing/stable dividends. Current pessimism has pushed their yields and valuations to attractive levels, providing a rare opportunity for both income and potential capital gains.

Secure Your Income: 3 Rock-Solid Dividend Stocks Yielding ~ 4%

24/7 Wall Street

2 Dividend Kings Reshaping Their Empires—Here's The Hidden Opportunity

Dividend Kings like Kimberly-Clark (KMB) and Procter & Gamble (PG) demonstrate financial resilience by increasing dividends for over 50 years, with recent restructurings aimed at enhancing profitability.

2 Dividend Kings Reshaping Their Empires—Here's The Hidden Opportunity

Zacks Investment Research

Suzano & Kimberly-Clark to Form Global Tissue Joint Venture

SUZ teams up with Kimberly-Clark to form a $3.4B global tissue JV spanning more than 70 countries and 22 facilities.

Suzano & Kimberly-Clark to Form Global Tissue Joint Venture

Kimberly-Clark sells majority stake in global tissue unit to Brazil's Suzano

Kimberly-Clark announced Thursday that it has reached an agreement with Brazilian pulp manufacturer Suzano to sell a controlling stake in its worldwide tissue business, valuing it at $3.4 billion.

Kimberly-Clark sells majority stake in global tissue unit to Brazil's Suzano

Kimberly-Clark To Sell Majority of $3.4B Global Tissue Business

Kimberly-Clark (KMB) on Thursday announced a partnership with Brazilian pulp and paper producer Suzano (SUZ) to split ownership of Kimberly-Clark's international tissue and paper products business.

Kimberly-Clark To Sell Majority of $3.4B Global Tissue Business

Kimberly-Clark in $3.4 Billion Deal to Sell International Tissue Business

Brazilian pulp and paper maker Suzano will hold a majority stake in a new venture.

Kimberly-Clark in $3.4 Billion Deal to Sell International Tissue Business

Kimberly-Clark to sell international tissue business in $3.4 billion deal

Kimberly-Clark will sell its international tissue business in a deal valued at about $3.4 billion, including debt, to Brazilian pulp maker Suzano , the Kleenex tissue maker said on Thursday.

Kimberly-Clark to sell international tissue business in $3.4 billion deal

See News Rankings

Charts implemented using Lightweight Charts™